Drug development is time‐consuming and expensive. Repurposing existing drugs for new
therapies is an attractive solution that accelerates drug development at reduced …

Pulmonary hypertension is a complex disease with multiple causes, corresponding to
phenotypic heterogeneity and variable therapeutic responses. Advancing understanding of …

The discovery of proper molecular signature from OMIC data is indispensable for
determining biological state, physiological condition, disease etiology, and therapeutic …

The high failure rate of clinical trials in Alzheimer's disease (AD) and AD-related dementia
(ADRD) is due to a lack of understanding of the pathophysiology of disease, and this deficit …

The rapid emergence of cardio-oncology has resulted in a rapid growth of cardio-oncology
programs, dedicated professional societies sections and committees, and multiple …

Rationale: Predictors of adverse outcome in pulmonary hypertension (PH) are well
established; however, data that inform survival are lacking. Objectives: We aim to identify …

The integration of artificial general intelligence (AGI) into personalized healthcare
represents a transformative approach to modernizing medical services, offering …

Study objective A multi-institutional interdisciplinary team was created to develop a research
group focused on leveraging artificial intelligence and informatics for cardio-oncology …

Cardiovascular disease is a leading cause of death among cancer survivors, second only to
cancer recurrence or development of new tumors. Cardio-oncology has therefore emerged …

Background Diabetic kidney disease (DKD) patients are facing an extremely high risk of
cardiovascular disease (CVD), which is a major cause of death for DKD patients. We aimed …